Delivery Order SPE2DX22D0010-SPE2D826FAP22
Award Date 10/23/25
Potential Completion Date 10/24/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,376.94 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, for the supply of Vyvanse 60 mg capsules. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of September 17, 2025, and will be performed at the company's Conshohocken facility. The...
- The Defense Department's Medical Supply Chain, through the Defense Logistics Agency (DLA), awarded a delivery order valued at $35,751.84 to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules 60mg. The contract was awarded on October 16, 2025, with an ultimate completion date of October 17, 2025, under firm fixed-price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 6, 2025, for the supply of Vyvanse capsules (20 mg) valued at $3,108.21. This firm fixed-price contract, which is set to be completed by October 7, 2025, supports the Medical Supply Chain division of the Defense Logistics Agency. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,783.60 on May 13, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) by the Defense Logistics Agency. This contract utilizes firm fixed pricing under a non-set-aside, competitively awarded arrangement with an ultimate completion date of May 14, 2025. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,377.46 by the Defense Logistics Agency on September 22, 2025, for the supply of Vyvanse 50 mg capsules (100 count). The award, which is not set-aside and employs firm fixed price terms, represents a single delivery order under a larger contract vehicle. This order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $12,936 firm fixed price delivery order for Vyvanse Caps 30mg on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside contract is funded by the Defense Logistics Agency's Medical Supply Chain and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $21,423.22 on June 18, 2025, for the supply of Vyvanse Caps 60mg to support the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 20, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete on an...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on August 29, 2025, for the supply of Vyvanse 60 mg capsules (100-count units). The contract was competitively awarded without set-aside designation and carries a ceiling value of $1,065.93, with a firm fixed price structure and an ultimate completion date of September 2, 2025. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 5, 2025, for the supply of Vyvanse 60 mg capsules (100-count units) with a contract value of $3,924.91. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The ultimate completion date is set for September 8, 2025, and the products will be delivered to the company's location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) with a contract value of $2,279.71 and a firm fixed price structure. The order is set to be completed by August 27, 2025, with fulfillment from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...